うっ血性心不全（CHF）治療装置の世界市場 2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Congestive Heart Failure (CHF) Treatment Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-04421 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、うっ血性心不全（CHF）治療装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。うっ血性心不全（CHF）治療装置の種類別市場規模（心臓再同期療法（CRT）、植込み型除細動器（ICD））、用途別市場規模（左室補助装置（LVAD）、右室補助装置（RVAD）、両心室補助装置（BIVAD））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abiomed、Medtronic、Boston Scientific Corporation、Berlin Heart GmbH、LivaNova PLC、Biotronik SE & Co. KG、Abbott、Jarvik Heart、HeartWare International、ReliantHeart ・地域別グローバル市場分析 2015年-2020年 ・うっ血性心不全（CHF）治療装置の北米市場（アメリカ、カナダ、メキシコ） ・うっ血性心不全（CHF）治療装置のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・うっ血性心不全（CHF）治療装置のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・うっ血性心不全（CHF）治療装置の南米市場（ブラジル、アルゼンチン） ・うっ血性心不全（CHF）治療装置の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：心臓再同期療法（CRT）、植込み型除細動器（ICD） ・用途別分析：左室補助装置（LVAD）、右室補助装置（RVAD）、両心室補助装置（BIVAD） ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Congestive Heart Failure (CHF) Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.0% in the forecast period of 2020 to 2025 and will expected to reach USD 5753.1 million by 2025, from USD 5114.7 million in 2019.

The Congestive Heart Failure (CHF) Treatment Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Congestive Heart Failure (CHF) Treatment Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Congestive Heart Failure (CHF) Treatment Devices market has been segmented into
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)

By Application, Congestive Heart Failure (CHF) Treatment Devices has been segmented into:
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Congestive Heart Failure (CHF) Treatment Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Congestive Heart Failure (CHF) Treatment Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Congestive Heart Failure (CHF) Treatment Devices market.

The report offers in-depth assessment of the growth and other aspects of the Congestive Heart Failure (CHF) Treatment Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Congestive Heart Failure (CHF) Treatment Devices Market Share Analysis
Congestive Heart Failure (CHF) Treatment Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Congestive Heart Failure (CHF) Treatment Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Congestive Heart Failure (CHF) Treatment Devices sales, revenue and market share for each player covered in this report.

The major players covered in Congestive Heart Failure (CHF) Treatment Devices are:
Abiomed
Medtronic
Boston Scientific Corporation
Berlin Heart GmbH
LivaNova PLC
Biotronik SE & Co. KG
Abbott
Jarvik Heart
HeartWare International
ReliantHeart

Among other players domestic and global, Congestive Heart Failure (CHF) Treatment Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Congestive Heart Failure (CHF) Treatment Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Congestive Heart Failure (CHF) Treatment Devices, with price, sales, revenue and global market share of Congestive Heart Failure (CHF) Treatment Devices in 2018 and 2019.
Chapter 3, the Congestive Heart Failure (CHF) Treatment Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Congestive Heart Failure (CHF) Treatment Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Congestive Heart Failure (CHF) Treatment Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Congestive Heart Failure (CHF) Treatment Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Congestive Heart Failure (CHF) Treatment Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cardiac Resynchronization Therapy (CRT)
1.2.3 Implantable Cardioverter Defibrillators (ICDs)
1.3 Market Analysis by Application
1.3.1 Overview: Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Left Ventricular Assist Device (LVAD)
1.3.3 Right Ventricular Assist Device (RVAD)
1.3.4 Biventricular Assist Device (BIVAD)
1.4 Overview of Global Congestive Heart Failure (CHF) Treatment Devices Market
1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abiomed
2.1.1 Abiomed Details
2.1.2 Abiomed Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abiomed SWOT Analysis
2.1.4 Abiomed Product and Services
2.1.5 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Medtronic SWOT Analysis
2.2.4 Medtronic Product and Services
2.2.5 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boston Scientific Corporation
2.3.1 Boston Scientific Corporation Details
2.3.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boston Scientific Corporation SWOT Analysis
2.3.4 Boston Scientific Corporation Product and Services
2.3.5 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Berlin Heart GmbH
2.4.1 Berlin Heart GmbH Details
2.4.2 Berlin Heart GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Berlin Heart GmbH SWOT Analysis
2.4.4 Berlin Heart GmbH Product and Services
2.4.5 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 LivaNova PLC
2.5.1 LivaNova PLC Details
2.5.2 LivaNova PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 LivaNova PLC SWOT Analysis
2.5.4 LivaNova PLC Product and Services
2.5.5 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biotronik SE & Co. KG
2.6.1 Biotronik SE & Co. KG Details
2.6.2 Biotronik SE & Co. KG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biotronik SE & Co. KG SWOT Analysis
2.6.4 Biotronik SE & Co. KG Product and Services
2.6.5 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abbott SWOT Analysis
2.7.4 Abbott Product and Services
2.7.5 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Jarvik Heart
2.8.1 Jarvik Heart Details
2.8.2 Jarvik Heart Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Jarvik Heart SWOT Analysis
2.8.4 Jarvik Heart Product and Services
2.8.5 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 HeartWare International
2.9.1 HeartWare International Details
2.9.2 HeartWare International Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 HeartWare International SWOT Analysis
2.9.4 HeartWare International Product and Services
2.9.5 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 ReliantHeart
2.10.1 ReliantHeart Details
2.10.2 ReliantHeart Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 ReliantHeart SWOT Analysis
2.10.4 ReliantHeart Product and Services
2.10.5 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Congestive Heart Failure (CHF) Treatment Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Congestive Heart Failure (CHF) Treatment Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
4.3 Europe Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
4.5 South America Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Country
5.1.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
5.3 Canada Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
6.3 UK Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
6.4 France Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
6.5 Russia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
6.6 Italy Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
7.3 Japan Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
7.4 Korea Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
7.5 India Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
7.7 Australia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Country
8.1.1 South America Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales and Market Share by Type (2015-2020)
10.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2015-2020)
11 Global Congestive Heart Failure (CHF) Treatment Devices Market Segment by Application
11.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2015-2020)
11.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2015-2020)
11.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Congestive Heart Failure (CHF) Treatment Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025)
12.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025)
12.2.4 South America Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025)
12.3 Congestive Heart Failure (CHF) Treatment Devices Market Forecast by Type (2021-2025)
12.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Share Forecast by Type (2021-2025)
12.4 Congestive Heart Failure (CHF) Treatment Devices Market Forecast by Application (2021-2025)
12.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abiomed Basic Information, Manufacturing Base and Competitors
Table 8. Abiomed Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 9. Abiomed Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 10. Abiomed SWOT Analysis
Table 11. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 12. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Medtronic Basic Information, Manufacturing Base and Competitors
Table 14. Medtronic Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 15. Medtronic Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 16. Medtronic SWOT Analysis
Table 17. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 18. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 21. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 22. Boston Scientific Corporation SWOT Analysis
Table 23. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 24. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Berlin Heart GmbH Basic Information, Manufacturing Base and Competitors
Table 26. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 27. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 28. Berlin Heart GmbH SWOT Analysis
Table 29. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 30. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. LivaNova PLC Basic Information, Manufacturing Base and Competitors
Table 32. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 33. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 34. LivaNova PLC SWOT Analysis
Table 35. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 36. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biotronik SE & Co. KG Basic Information, Manufacturing Base and Competitors
Table 38. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 39. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 40. Biotronik SE & Co. KG SWOT Analysis
Table 41. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 42. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Abbott Basic Information, Manufacturing Base and Competitors
Table 44. Abbott Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 45. Abbott Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 46. Abbott SWOT Analysis
Table 47. Abbott Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 48. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Jarvik Heart Basic Information, Manufacturing Base and Competitors
Table 50. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 51. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 52. Jarvik Heart SWOT Analysis
Table 53. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 54. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. HeartWare International Basic Information, Manufacturing Base and Competitors
Table 56. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 57. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 58. HeartWare International SWOT Analysis
Table 59. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 60. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. ReliantHeart Basic Information, Manufacturing Base and Competitors
Table 62. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Major Business
Table 63. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Total Revenue (USD Million) (2017-2018)
Table 64. ReliantHeart SWOT Analysis
Table 65. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product and Services
Table 66. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Regions (2015-2020) (K Units)
Table 70. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Regions (2015-2020)
Table 71. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Countries (2015-2020) (K Units)
Table 73. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Countries (2015-2020)
Table 74. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries (2015-2020)
Table 76. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Countries (2015-2020) (K Units)
Table 77. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Countries (2015-2020)
Table 78. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Congestive Heart Failure (CHF) Treatment Devices Sales by Countries (2015-2020) (K Units)
Table 83. South America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Countries (2015-2020)
Table 84. South America Congestive Heart Failure (CHF) Treatment Devices Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries (2015-2020)
Table 90. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2015-2020) (K Units)
Table 91. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2015-2020)
Table 92. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2015-2020) (USD Million)
Table 93. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2015-2020)
Table 94. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2015-2020) (K Units)
Table 95. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2015-2020)
Table 96. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Congestive Heart Failure (CHF) Treatment Devices Market Share Forecast by Regions (2021-2025)
Table 98. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Congestive Heart Failure (CHF) Treatment Devices Market Share Forecast by Type (2021-2025)
Table 100. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2021-2025)
Table 101. Global Congestive Heart Failure (CHF) Treatment Devices Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Congestive Heart Failure (CHF) Treatment Devices Picture
Figure 2. Global Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Type in 2019
Figure 3. Cardiac Resynchronization Therapy (CRT) Picture
Figure 4. Implantable Cardioverter Defibrillators (ICDs) Picture
Figure 5. Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2018
Figure 6. Left Ventricular Assist Device (LVAD) Picture
Figure 7. Right Ventricular Assist Device (RVAD) Picture
Figure 8. Biventricular Assist Device (BIVAD) Picture
Figure 9. Global Congestive Heart Failure (CHF) Treatment Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturer in 2019
Figure 30. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Congestive Heart Failure (CHF) Treatment Devices Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Congestive Heart Failure (CHF) Treatment Devices Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Regions (2015-2020)
Figure 37. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Regions in 2018
Figure 38. North America Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
Figure 39. Europe Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
Figure 41. South America Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020)
Figure 43. North America Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Countries (2015-2020)
Figure 45. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Countries in 2018
Figure 46. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries in 2018
Figure 48. United States Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries in 2019
Figure 54. Germany Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Regions 2019
Figure 62. China Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Countries in 2019
Figure 69. South America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries in 2019
Figure 70. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Congestive Heart Failure (CHF) Treatment Devices Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Congestive Heart Failure (CHF) Treatment Devices Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel

---